An Open Label Pharmacokinetic Study Of Gabapentin In Japanese Subjects With Renal Impairment Including Hemodialysis.

Trial Profile

An Open Label Pharmacokinetic Study Of Gabapentin In Japanese Subjects With Renal Impairment Including Hemodialysis.

Discontinued
Phase of Trial: Phase IV

Latest Information Update: 23 Mar 2017

At a glance

  • Drugs Gabapentin (Primary)
  • Indications Epilepsy
  • Focus Pharmacokinetics
  • Sponsors Pfizer
  • Most Recent Events

    • 28 Oct 2008 Actual patient number (8) added as reported by ClinicalTrials.gov.
    • 28 Oct 2008 Planned end date changed from 1 Dec 2008 to 1 Dec 2007 as reported by ClinicalTrials.gov.
    • 28 Oct 2008 Status changed from active, no longer recruiting to discontinued as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top